Bioconjugation and ADC - CARBOGEN AMCIS x Celonic collaboration - Brochure
Brochure
Bioconjugation & Antibody Drug Conjugates
Download the brochure on CARBOGEN AMCIS x Celonic collaborationÂ
To further strengthen our ADC offering, CARBOGEN AMCIS has established a strategic partnership with Celonic, a leading biologics CDMO. This collaboration enables a seamless integration of monoclonal antibody development and manufacturing with CARBOGEN AMCIS’s expertise in payload synthesis, conjugation, and sterile fill-finish, reducing interfaces and accelerating timelines for ADC innovators.

Download the CARBOGEN AMCIS x Celonic collaboration brochure now: